FDA NDC Directory · JSON-LD · Markdown

BEYFORTUS

NDC 49281-574 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namenirsevimab
Labeler / ManufacturerSanofi Vaccines US Inc.
Marketing categoryBiologic License Application · App BLA761328
Dosage form / routeINJECTION · INTRAMUSCULAR
Active ingredientsNIRSEVIMAB (100 mg/mL)
Marketing started20230718
Package count2

External sources

Source: openFDA. Public-domain (CC0).